Group 1 - The fifth "Asian Healthcare Summit" held in Hong Kong attracted over 2,800 participants from more than 40 countries and regions, focusing on future development and cooperation opportunities in the global healthcare sector [1] - A key topic discussed was scientific anti-aging and achieving healthy aging in the context of the global "silver wave," with significant interest in the research on Ba Zi Bu Shen capsules based on traditional Chinese medicine [1][2] - The population aged 60 and above in China exceeded 300 million by the end of last year, accounting for 22% of the total population, highlighting the increasing health issues associated with aging [2] Group 2 - The theory of Qi Luo and the essence-spirit theory posits that the core of aging is "kidney essence deficiency," and "tonifying kidney essence" is crucial for anti-aging [2] - Ba Zi Bu Shen capsules have been shown to intervene in 10 biological markers of aging, including maintaining stem cell vitality and reducing telomere loss, aligning with recent findings in Western medicine [2] - A clinical study published in the journal "Phytomedicine" demonstrated that Ba Zi Bu Shen capsules significantly improved aging symptoms in participants aged 30 to 78 over a 12-week intervention, with a 76.7% increase in telomerase activity compared to the placebo group [3][4] Group 3 - The research on Ba Zi Bu Shen capsules shows significant systemic intervention effects on nine major bodily systems, including nervous, circulatory, and immune systems [4] - The Chinese government is actively supporting research in this area, with a key project focusing on the evaluation and integration mechanisms of traditional Chinese medicine for anti-aging [4] - The summit established a "Silver Health Chapter" to address the challenges of population aging, emphasizing the role of scientific research in traditional Chinese medicine as a bridge between Eastern and Western approaches to aging [5]